HEALTHCARE M&A & STRATEGIC ADVISORY

Global Vision.
Local Expertise.
Trusted Partners.

Connecting proprietary opportunity access with specialist healthcare judgement and cross-border transaction expertise.

Explore our expertiseCHC Intelligence
LOCAL RELATIONSHIPS. INTERNATIONAL PERSPECTIVE.

London · Shanghai · Hong Kong

ABOUT CHC

Healthcare-focused. Trusted partners.

CHC Capital Partners advises healthcare companies and investors on M&A, licensing, partnerships and strategic growth across international markets.

Opportunity access. Strategic judgement.

We combine direct relationships with China biotech innovators and international decision-makers with strategic, financial and transaction capabilities.

Senior-led advice connects local industry knowledge with each client’s objectives — from proprietary origination and evaluation to negotiation and agreed execution.

Our advisory approach
Tower Bridge and the London skyline
Cross-border relationships.Healthcare expertise.
15+

Years healthcare experience

78+

Active biotech assets

US$10B+

Asset value¹

18+

Healthcare markets

Company-reported figures. ¹ Active asset value, not AUM or completed transaction value.

HEALTHCARE FOCUS

Healthcare Industry Focus

Deep sector expertise across the healthcare landscape

Pharmaceuticals

Branded, generic and specialty portfolios, from emerging pharma to global leaders.

Biotechnology

Innovative therapeutics and discovery platforms across development stages.

MedTech

Medical devices, diagnostics and enabling technologies.

HealthTech & Digital Health

Digital care, healthcare software and AI-enabled solutions.

Consumer Health

OTC, wellness, nutraceuticals and preventive health.

Healthcare Services

Providers, CROs, CDMOs and diagnostics services.

OUR SERVICES

Specialist advice. Across the transaction.

Healthcare M&A & Strategic Advisory — tailored to the opportunity, the client and the mandate.

Mergers & Acquisitions

Buy-side and sell-side transactions, including cross-border acquisitions and divestments.

Licensing & Partnerships

Licensing, co-development and commercial partnerships for healthcare assets.

Strategic Advisory

Market entry, portfolio strategy and growth priorities.

Financial Advisory

Financial modelling, capital planning and transaction structuring, excluding regulated securities activities.

Valuation & Due Diligence

Company and asset valuation, commercial due diligence and transaction analysis.

Joint Ventures

Cross-border joint ventures and strategic alliances.

Disclaimer: CHC Capital Partners provides corporate, strategic, and financial advisory services exclusively. We do not provide regulated investment advice, securities dealing, or asset management services as defined by the UK Financial Conduct Authority (FCA) or the Hong Kong Securities and Futures Commission (SFC).
STRATEGIC ORIGINATION & TRANSACTIONS ADVISORY

From relationships to actionable opportunities.

Proprietary access, strategic judgement and transaction execution for buyers and sellers.

BUY-SIDE ADVISORY

Identify. Evaluate. Develop.

Source and qualify opportunities, engage management and advance due diligence, valuation, negotiation and execution.

SELL-SIDE ADVISORY

Position. Connect. Advance.

Position assets, engage the right buyers and partners, and manage transaction development through negotiation and execution.

Execution responsibilities are agreed for each mandate. CHC can work directly with the client or alongside appointed legal, financial and specialist advisers.

CHC INTELLIGENCE

Insight that informs the next decision.

CHC’s intelligence platform combines healthcare market insight, asset research and AI-assisted screening.

Explore CHC Intelligence

CHC AI Agents

Within BioAccess, AI-assisted tools turn your priorities into a focused shortlist and opportunity briefing — supporting professional judgement.

AI-assisted outputs support professional judgement and require independent verification.

OUR PEOPLE

Senior expertise. Personal commitment.

Healthcare experience and international relationships, brought together around each client’s priorities.

Professionals collaborating in an officeSpecialist judgement.Collaborative approach.

Senior-led, partner-focused

Extensive global network of executives at Big Pharma and MedTech companies, entrepreneurs in biotech, health-tech, and healthcare services, and healthcare investors

  • Former executives from top-tier investment banks, MBB firms, and global healthcare corporates
  • Average of 15+ years of healthcare advisory, investment, and industry experience
  • Multilingual professionals with deep expertise in cross-border healthcare markets
Speak with CHC
CONTACT CHC

Let’s build the next opportunity.

A confidential conversation about your strategic priorities — and where CHC can add value.

Email usStart a confidential discussion Call usSpeak with CHC Our PresenceLondon · Shanghai · Hong Kong

Global Vision. Local Expertise. Trusted Partners.

CHC Intelligence